Wu R - Search Results

1

Lymph Node Metastases in Colon Cancer Are Polyclonal.

Ulintz PJ, Greenson JK, Wu R, Fearon ER, Hardiman KM. Ulintz PJ, et al. Among authors: wu r. Clin Cancer Res. 2018 May 1;24(9):2214-2224. doi: 10.1158/1078-0432.CCR-17-1425. Epub 2017 Dec 4. Clin Cancer Res. 2018. PMID: 29203589 Free PMC article.

2

Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.

Wu R, Connolly DC, Ren X, Fearon ER, Cho KR. Wu R, et al. Neoplasia. 1999 Oct;1(4):311-4. doi: 10.1038/sj.neo.7900042. Neoplasia. 1999. PMID: 10935485 Free PMC article.

3

Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.

Connolly DC, Greenspan DL, Wu R, Ren X, Dunn RL, Shah KV, Jones RW, Bosch FX, Muñoz N, Cho KR. Connolly DC, et al. Among authors: wu r. Clin Cancer Res. 2000 Sep;6(9):3505-10. Clin Cancer Res. 2000. PMID: 10999736

4

Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.

Wu R, Zhai Y, Fearon ER, Cho KR. Wu R, et al. Cancer Res. 2001 Nov 15;61(22):8247-55. Cancer Res. 2001. PMID: 11719457

5

Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.

Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER. Leung JY, et al. Among authors: wu r. J Biol Chem. 2002 Jun 14;277(24):21657-65. doi: 10.1074/jbc.M200139200. Epub 2002 Apr 8. J Biol Chem. 2002. PMID: 11940574 Free article.

6

Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas.

Zhai Y, Wu R, Schwartz DR, Darrah D, Reed H, Kolligs FT, Nieman MT, Fearon ER, Cho KR. Zhai Y, et al. Among authors: wu r. Am J Pathol. 2002 Apr;160(4):1229-38. doi: 10.1016/s0002-9440(10)62550-3. Am J Pathol. 2002. PMID: 11943708 Free PMC article.

7

ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.

Kolligs FT, Nieman MT, Winer I, Hu G, Van Mater D, Feng Y, Smith IM, Wu R, Zhai Y, Cho KR, Fearon ER. Kolligs FT, et al. Among authors: wu r. Cancer Cell. 2002 Mar;1(2):145-55. doi: 10.1016/s1535-6108(02)00035-1. Cancer Cell. 2002. PMID: 12086873 Free article.

8

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR. Schwartz DR, et al. Among authors: wu r. Cancer Res. 2002 Aug 15;62(16):4722-9. Cancer Res. 2002. PMID: 12183431

9

Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas.

Wu R, Lin L, Beer DG, Ellenson LH, Lamb BJ, Rouillard JM, Kuick R, Hanash S, Schwartz DR, Fearon ER, Cho KR. Wu R, et al. Am J Pathol. 2003 May;162(5):1603-10. doi: 10.1016/S0002-9440(10)64294-0. Am J Pathol. 2003. PMID: 12707044 Free PMC article.

10

Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.

Schwartz DR, Wu R, Kardia SL, Levin AM, Huang CC, Shedden KA, Kuick R, Misek DE, Hanash SM, Taylor JM, Reed H, Hendrix N, Zhai Y, Fearon ER, Cho KR. Schwartz DR, et al. Among authors: wu r. Cancer Res. 2003 Jun 1;63(11):2913-22. Cancer Res. 2003. PMID: 12782598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,009 results

Search Page

Filters